September 11 – 13, 2020 (Friday – Sunday)
<p>Collegium Pharmaceutical is a specialty pharmaceutical company committed to being the leader in responsible pain management. For nearly two decades, Collegium has been focused on developing and commercializing new medicines for pain management that reflect our Core Values and our commitment to people suffering from pain, providers and our communities. The result of those efforts is a portfolio of medications to treat moderate to severe pain.</p>
Pfizer & Lilly
<div style="width: 600px;"><img src="https://f.hubspotusercontent10.net/hubfs/6970566/Hero%20Image_09.01.jpg%5B35%5D.jpg" width="600" alt=""/><br> </div><br><div style="width: 600px;"> <div style="float: right;" align="right"><a href="https://www.pfizermedicalinformation.com/en-us" target="_blank"><img src="https://resources.painweek.org/CPD-MedInfo-btn.png" width="225" height="59" style="vertical-align: top;" /></a></div><div style="width: 300px; border-right: 1px solid black;"><a href="https://www.vr-exhibit.com/alliance/004" target="_blank"><img src="https://resources.painweek.org/CPD-Learn-btn.png" width="225" height="59" /></a><br /><img src="https://www.painweek.org/sites/medical/painweek/files/New%20Science%20D%20copy.png" width="225" height="106" /></div></div> PP-N1N-USA-0800 © 2020 Pfizer Inc. All rights reserved. August 2020
Salix Pharmaceuticals is one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal diseases. For more than 30 years, Salix has licensed and developed treatments for many chronic and debilitating conditions. Salix currently markets its product line to U.S. healthcare providers through multi-channel efforts, including an expanded sales force. Salix is headquartered in Bridgewater, New Jersey. For more information about Salix, visit www.Salix.com and connect with us on Twitter and LinkedIn.
Teva Pharmaceuticals has been developing and producing medicines to improve people’s lives for more than a century. We are a global leader in generic and specialty medicines with a portfolio consisting of over 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day, and are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. In this site, learn more about Teva’s ongoing commitment and experience in neurological conditions like migraine. ______________________________________________________________________________________ Regeneron and Teva have also partnered to research chronic pain and further our understanding of the burden for adults living with chronic pain associated with OA.
Emergent BioSolutions is a global life sciences company dedicated to one simple mission—to protect and enhance life. We develop, manufacture, and deliver a portfolio of medical countermeasures for biological and chemical threats as well as emerging infectious diseases. Additional information about the company may be found at www.emergentbiosolutions.com
RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on gastrointestinal diseases. RedHill’s U.S. commercial operations, headquartered in Raleigh, NC, include a gastrointestinal-focused sales force promoting specialty gastrointestinal drugs in the U.S. RedHill’s pipeline includes several drug candidates in advanced stages of clinical development, addressing clear medical needs and aiming to relieve suffering.
<span style="color: #00225d; font-weight:bold; font-size: 22px;">Welcome! Thank you for your interest in Salonpas.</span><span style="color: #00ab67; font-size: 18px; font-weight: normal;"><br>Salonpas<span style="vertical-align: baseline; font-size: 9px;">®</span> topical analgesics are proven, powerful and safe treatments for pain. Explore the Product Showcase and Resources tabs at left to learn more about our products, the clinical proof of their effectiveness, and the prestigious health authorities and societies that recommend topicals like ours as first-line therapies. And don’t forget to request free samples (button above) to see for yourself why we say, <span style="font-weight:bold;">“Salonpas. It’s Good Medicine!”</span></span> <span style="font-weight: bold;"><br>Prefer to talk to someone LIVE?</span> <span>The Salonpas Brand Team is available to take your questions and provide you all the details regarding Salonpas products. See Video Chat section (left) and hover over image to see complete live schedules.</span> <span style="font-weight: bold;"><br>ACP and AAFP recommendation</span> <span>The ACP and AAFP just issued a strong recommendation for topical NSAIDs as first-line treatment for non-low back musculoskeletal pain. Salonpas Pain Relief Patch Large is the first and only OTC topical NSAID indicated to treat mild to moderate pain. <a href="https://bit.ly/31M6BFA" target="_blank" style="color: #00225d; text-decoration: underline;">Learn more</a><br></span> <a href="https://us.hisamitsu/salonpas-samples" target="_blank" style="text-decoration: none;"><img src="https://www.conferenceharvester.com//uploads/harvester/expo/productshowcase/9929/UPSMDZRR-132148-383007-5-PDF.png" width="140" height="auto" alt=""/></a>
Welcome and thank you for stopping by our virtual booth at PainWeek! SPRINT® PNS System - A Breakthrough in Pain Management The SPRINT® Peripheral Nerve Stimulation (PNS) System, by SPR Therapeutics, marks an innovative shift in the treatment of pain. Our breakthrough 60-day treatment is proven to provide significant and sustained relief from chronic pain and works by selectively stimulating targeted peripheral nerve fibers. The SPRINT System helps patients get back to living without a permanent implant, nerve damage or risk of addiction. The system has been studied extensively for low back, shoulder and post-amputation pain, as well as chronic and acute post-operative pain, and is cleared for use up to 60 days. Recognized by leading pain management centers, the breakthrough neuromodulation treatment offers a patient-preferred alternative to more invasive options. “A 60-day percutaneous treatment that delivers long-term relief without a permanent implant...this is a game changer.” — Peter Staats MD, MBA, DABA, ABIPP, FIPP Visit us at SprintPNS.com: • View the clinical evidence across 30+ peer-reviewed publications • See how the SPRINT PNS works to Outsmart Pain™ • Hear from our patients on how SPRINT PNS has allowed them to Get Back to Life™ Please contact us for more information! Email us at TellMeMore@SprintPNS.com. One of our SPRINT PNS specialists will be in touch to discuss how you can champion a new protocol of care. (Please note that currently SPRINT PNS is not available outside the US.) Rethink your pain strategy™ with SPRINT PNS!
Theranica Company Description: Theranica has a highly experienced team that has set a goal to translate our technological and business knowledge in mobile digital solutions to the field of pain therapeutics. We develop non-invasive, drug-free, personalized and affordable wearable therapeutic products for the treatment of pain by integrating the latest neuroscience research with notable technological expertise. Theranica’s novel smartphone-controlled prescription migraine wearable device, Nerivio®, is recognized in TIME Magazine's annual list of the 100 Best Inventions.
PAINWeek 2021 Las Vegas
<a href="https://www.eventscribe.com/2020/painweek/aaStatic.asp?SFP=SFpTTURGWEtANDY1OQ">What I Learned….at PAINWeek Live Virtual Conference 2020</a><br/><br/>PAINWeek is the preferred resource for frontline practitioners treating acute and chronic pain. For over a decade, we have demonstrated that “education is the best analgesic’’ by presenting over 12,000 hours of content across our national and regional conferences, conducting hundreds of Expert Opinion interviews, and publishing an array of faculty authored articles in our quarterly journal.<br><br>Be it live, digital, or print, PAINWeek provides education and insight 365 days/year!
Millennium Health is an accredited specialty laboratory with over a decade of experience delivering timely, accurate, clinically-actionable information through our nationwide medication monitoring and drug testing services. Processing hundreds of thousands of specimens each year allows us to provide real-time analytics regarding emerging drug use trends, such as our studies published in JAMA Network Open and the Millennium Health Signals Report™ and has resulted in our collaboration with the U.S. Department of Health and Human Services to help fight our nation’s drug overdose crisis. We also offer evidence-based, guideline-driven pharmacogenetic testing helping clinicians make more informed medication choices.
American Society of Interventional Pain Physicians
The American Society of Interventional Pain Physicians(ASIPP) is a national society supporting the needs of physicians who practice Interventional Pain Management. ASIPP accomplishes this through excellence in advocacy, education, publications, certifications and communications. ASIPP was formed in 1998 with the goal of promoting the development and practice of safe, high quality yet cost effective interventional pain management techniques for the diagnosis and treatment of pain and related disorders, and to ensure patient access to these interventions.
The IPPS is a network of professionals committed to a biopsychosocial and interdisciplinary approach to the treatment of conditions associated with chronic pelvic pain (CPP) which negatively affects millions of people across the gender identity spectrum. CPP can impact a person’s physical, emotional, social and material well-being. It is the mission of IPPS to promote education about interdisciplinary approaches to the evaluation and treatment of CPP, support individuals living with this by improving access to care, and supporting physical and emotional well-being, and raising awareness through education, outreach and engagement and ultimately improving the lives of patients worldwide. Join us for our 23rd Annual Scientific Meeting, Virtual Conference on Pelvic Pain being held in October. Also show your support by joining our Virtual Challenge: Move Against Pelvic Pain!
Pain Medicine News
Pain Medicine News, the most widely read pain publication in the United States according to Kantar Media, is mailed to 41,554 pain-treating physicians and to 41,158 pain-treating nurse practitioners and physician assistants. It offers extensive coverage of major scientific meetings affecting the specialty, feature articles on topics relevant to practicing provider, in-depth clinical reviews, practice management articles, medical education, as well as a full line of digital media, including the PainMedicineNews.com website, e-Newsletters, and multimedia content.
Clarius Mobile Health
JOIN OUR LIVE DEMOS OF HANDHELD ULTRASOUND FOR PAIN MANAGEMENT! 👉🏼 Join us at www.clarius.com/live-demo 👈🏼 With high definition nerve and musculoskeletal (MSK) imaging, Clarius HD is the ideal wireless ultrasound system for safe, accurate procedure guidance. It delivers the power and image quality of larger, more expensive systems in an affordable device that fits in your pocket and works most iOS or Android smart devices. Eliminate lengthy palpation with instant musculoskeletal imaging to optimize diagnostic accuracy and surgical planning. You’ll clearly see anatomy and your needle in real-time for 100% accuracy while performing deeper injections. Clarius HD takes the guesswork out of pain management, enhancing confidence and the overall patient experience. "Wireless ultrasound enables me to focus more on my patient without having wires get in the way of my nerve block. The image quality is superior. With the versatility of the iPad and Clarius Cloud, you could do a lot of good work and help a lot of people." - David Rosenblum, MD 🎁 ENTER TO WIN A FREE IPAD AT www.clarius.com/painweek 🎁
A unique pharmaceutical company, Galt has found a better way to enhance the quality of life of patients with products that meet unmet clinical needs, while creating life-changing opportunities for entrepreneurs, employees and the individuals within the communities served. Galt is the first and only pharmaceutical company to create a unique “Phranchise™” concept. Galt's product portfolio includes therapeutics in both PAIN and SLEEP, with a robust pipeline that supports a strong commitment of continuing to bring alternative pain medications to market.
Baudax Bio, Inc.
Baudax Bio is a specialty pharmaceutical company focused on developing and commercializing innovative products for acute care settings. We are committed to bringing clinically meaningful therapeutic options to patients, healthcare providers, and payers. Baudax Bio was founded in 2019 when Recro Pharma, Inc separated its Acute Care Division from its Manufacturing Organization.
International Myopain Society
The International MYOPAIN Society [IMS] is a nonprofit, international, interdisciplinary medical organization for research scientists, physicians, other health care professionals, individuals in training toward a health-related career, institutions, foundations, and commercial companies interested in exchanging ideas, conducting research, or learning more about soft tissue pain syndromes like myofascial pain syndrome and fibromyalgia syndrome. The IMS brings together an international community of health care professionals, researchers, educators, and others to improve care and transform delivery of treatment to those suffering from soft tissue pain through the promotion and exchange of globally recognized research, education, and innovation in patient care.
American Society of Pain and Neuroscience
Our Mission Statement The American Society of Pain and Neuroscience is dedicated to advancement in the fields of Pain and Neuroscience. All initiatives of ASPN are dedicated to improving patient outcomes, education, research, and innovation. ASPN is committed to achieving its goals by embracing diversity that is inclusive to individuals of all genders, cultures, age, race, sexual orientation, and profession. A Different "Pain Society" ASPN was created to harness the talents of brightest minds in our profession. Innovative committees, educational meetings, and collaborative publications set ASPN apart as a unique society. Interventional Pain Medicine is an unprecedented time of innovation and growth. Advancements in neuromodulation, minimally invasive spine procedures, regenerative medicine, and other areas requires a society of the top thought leaders to shape the safe, effective, and responsible utilization of these treatments.
Abacus Health Products
CBD CLINIC™'s products are the first non-prescription creams, ointments, and oils that combine authorized over-the-counter active ingredients, plant extracts, and natural emollients including CBD. These products are developed and manufactured on the foundation of 15 years of pharmaceutical experience specializing in topical formulations using natural ingredients. CBD CLINIC joined Charlotte’s Web™ family in early 2020. The combined strength of brands means that you will continue to receive the same great products backed by a stronger supply chain, a larger scientific team, more education, and future innovations customized to your patient and client needs. Contact our experts to help to choose the right product for your practice. Rony Serrato Customer Success email@example.com 401.234.0701 888-422-3254 | www.cbdclinic.co | firstname.lastname@example.org 1600 Pearl St., Suite 300, Boulder, CO 80302 ©️ 2020 Abacus Health Product, Inc. All rights reserved. Charlotte’s Web™ and Charlotte’s Web™ logo are trademarks for Charlotte’s Web, Inc.
Taylor & Francis
Taylor & Francis Group is the academic publishing division of Informa PLC and encompasses both Taylor & Francis and Dove Medical Press. We publish a number of high impact, peer-reviewed journals across the clinical spectrum with open access and accelerated publication options, as well as publishing a number of books and reference works. We are providers of quality information and knowledge that enable our customers to perform their jobs efficiently, enhance their education, and help contribute to the advancement of their chosen market sectors. Informa PLC is one of the world’s leading business intelligence, academic publishing, knowledge and events businesses. With more than 6,500 employees globally, it has a presence in all major geographies, including North America, South America, Asia, Europe, the Middle East and Africa. About Postgraduate Medicine Postgraduate Medicine provides an essential platform to display and communicate the latest relevant medical information and breakthroughs in pain management treatments, aiming to help physicians solve clinical problems and improve patient care. The journal is currently looking for articles with a pain management theme for a focus issue which will be released in January 2021. These articles will benefit from an increased impact factor (2019 - 2.464) and a growing readership. Please download our brochure for details on getting 20% off on accelerated publications.
Consumer Healthcare Products Association’s Acetaminophen Awareness Coalition
The Acetaminophen Awareness Coalition (AAC) is made up of leading health, healthcare provider, and consumer organizations aiming to educate consumers and patients on the importance of safely using acetaminophen through its campaign, Know Your Dose. By reaching consumers and patients when medicine safety is top of mind, Know Your Dose seeks to raise awareness and promote safe acetaminophen use to prevent unintentional acetaminophen overdose. This cold and flu season, with the additional presence of COVID-19, it is critical to remind your patients about safely using acetaminophen to help relieve their symptoms. Know Your Dose has educational materials available for patients and healthcare providers to spread awareness about acetaminophen safe use. Download and order free materials at KnowYourDose.org today.
International Pain Foundation
The International Pain Foundation (iPain) is devoted to advancing access and quality care in order to help people suffering from a variety of muscular skeletal, inflammatory, neurological, emotional, degenerative and often rare conditions that involve chronic pain through education, awareness, and access to care projects. - iPain Living Magazine® - iPain Summit - iRunForiPain - NERVEmber® - and more! * GuideStar PLATINUM Rating * iPain Foundations objectives are reached through important educational events, support, resources, and enhancement projects that are funded through private donations and grants. The Power of Pain Foundation (dba: International Pain Foundation) demonstrates its commitment to the chronic pain community by promoting new knowledge in the cause and treatment of chronic pain conditions. The ultimate goal is to provide tools and life skills to chronic pain patients giving them the ability to perform their regular activities in the community and to bolster society’s ability to provide full opportunities and appropriate supports. Supporting education for pain patients, family members, caregivers and medical professionals, we make an important contribution to the overall knowledge and treatment of chronic pain. This allows our foundation to affect the lives of millions of people with chronic pain worldwide. Whether you have pain or are a caregiver, family member or friend of someone diagnosed, we’ll help you face the challenges and life changes of chronic pain, head on. The Power of Pain Foundation was originally registered as a not-for-profit founded in the state of Virginia as a 501-C-3 association. The idea for POPF was first conceived on November 23, 2006 with the mandate of providing educational, emotional and physical support that assists chronic pain patients and public awareness with Neuropathy conditions. Our 501(C)(3) status was awarded by the IRS in March, 2007. In Feb. 2015 The POPF was updated to a 501-C-3 corporation based out of Arizona and assigned a new tax id of 47-3080556 with an upgrade in the name to Power of Pain Foundation Inc. We have been growing fast and have been working internationally on projects and collaborations since 2009 and increased those efforts in 2011. As of January 1, 2016 our board of directors decided that a better way to represent what we do was upgrade our name. We are now doing charity business as International Pain Foundation (iPain). More on our programs at www.internationalpain.org.
We are excited to announce that QUTENZA is now FDA approved for the treatment of painful diabetic peripheral neuropathy (PDPN) of the feet. Learn more by joining us at our virtual symposium event: Treatment Advances in Painful Diabetic Peripheral Neuropathy (PDPN) of the Feet: Integrating Prescription-Strength Capsaicin into Your Office Procedures Saturday, September 12, 2020 11:00–11:45 AM ET Moderated by: Jeffrey Fudin, PharmD (US) Speakers include: David M. Simpson, MD (US) Prof. Dr. Eric Viel (FR) Also, join us at the QUTENZA booth to meet and have a discussion with key guests for our "Meet the Experts" series. Friday, September 11, 2020 11:00 am - 11:45 am ET David M. Simpson, MD 12:15 pm - 1:00 pm ET Eric J. Viel, MD, PhD and Sean Li, MD Saturday, September 12 2:30 pm - 3:15 pm ET David M. Simpson, MD and Sean Li, M.D. 3:15 pm - 4:00 pm ET Miroslav "Misha" Backonja, MD INDICATION QUTENZA® (capsaicin) 8% patch is indicated in adults for the treatment of neuropathic pain associated with postherpetic neuralgia (PHN) and for neuropathic pain associated with diabetic peripheral neuropathy (DPN) of the feet. IMPORTANT SAFETY INFORMATION Do not dispense QUTENZA to patients for self-administration or handling. Only physicians or healthcare professionals under the close supervision of a physician are to administer and handle QUTENZA. Unintended exposure to capsaicin can cause severe irritation of eyes, mucous membranes, respiratory tract, and skin in healthcare providers and others. When administering QUTENZA, it is important to follow these procedures: • Administer QUTENZA in a well-ventilated treatment area. • Wear only nitrile gloves when handling QUTENZA or any item that makes contact with QUTENZA, and when cleaning capsaicin residue from the skin. Do not use latex gloves as they do not provide adequate protection. Please see Full Important Safety Information: https://www.qutenza.com/hcp/important-safety-information/ QUTENZA® is a registered trademark of Averitas Pharma, Inc. © 2020 Averitas Pharma, Inc. All rights reserved. M-QZA-US-08-20-0031 September 2020
Osteoarthritis Research Society International
OARSI is the premier international organization for scientists and health care professionals focused on the prevention and treatment of osteoarthritis through the promotion and presentation of research, education and the worldwide dissemination of new knowledge.
Global Education Group
Global Education Group is the accredited provider for PAINWeek 2020. This conference is certified for the following types of credit: ACCME (Physicians), ABIM MOC (Physicians), ANCC (Nurses), ACPE (Pharmacists), AANP (Nurse Practitioners, APA (Psychologists), AAFP (American Academy of Family Practitioners, ACEND (CA Physical Therapist). In order to receive credit, you must complete the evaluation/application for credit at the end of the conference. Upon completion, you will be able to download you certificate. If you have any questions regarding the certification of this conference, please contact us at: email@example.com
Patient Mind Inc.
Patient Mind Inc. is a 501(c)(3) on a mission to improve clinical dialogue by closing the knowledge gap between Clinicians and Patients. Patient Mind Inc. is a virtual community that provides tools for CONFIDENT clinical interactions. When struggling with pain and/or mental health conditions, it's challenging to find a place to start. Our goal is to provide you with real stories, education content with real solutions, and a place for hope. Here, you will find specialists in your area, and we will provide you with the latest science and therapies, so you are prepared and confident in your next clinical visit.
North American Neuromodulation Society
The North American Neuromodulation Society (NANS), formerly the American Neuromodulation Society (ANS), was formed in 1994 through the efforts of physicians dedicated to patient care through the field of neuromodulation. NANS is a non-profit organization devoted to the advancement of the field of neuromodulation within the United States. NANS is devoted to the pursuit of excellence in the application of all neuromodulation therapies. We accomplish our mission and vision by addressing the clinical and professional educational needs of physicians and scientists, ensuring excellence in patient care utilizing regional anesthesia and pain medicine, and investigating the scientific basis of the specialty. Neuromodulation is often defined as the application of targeted electrical, chemical and biological technologies to the nervous system in order to improve function and quality of life. We are actively involved in the following areas: - Developing standards of education for implanters through an education continuum designed to educate at all levels of involvement in neuromodulation. - Advocacy for practitioners and improving patient access to this therapy. - Establishing best practices. - Outreach to medical specialties involved in using this treatment modality.
UCI/UCD Train New Trainers Primary Care Psychiatry Fellowship
Primary care providers are on the frontline for the delivery of psychiatric treatment. However, these providers are under-resourced and often have suboptimal training to support the vast majority of psychiatric care. The Train New Trainers (TNT) Primary Care Psychiatry (PCP) Fellowship program lays the groundwork for an expansion of psychiatric education for primary care specialists currently in practice, and who are providing the bulk of care for patients with behavioral health issues. We are currently accepting applications for the 2021 Cohort. Apply now: https://tntpcp.secure-platform.com/a/solicitations/1/home
Veterans In Pain
Veterans In Pain - V.I.P. is an IRS-Certified 501(c)3 Nonprofit Facilitating OrthoBiologic & Alternative Medical Solutions for Veterans Suffering from Chronic Pain, by Connecting Volunteer Physicians with our Country’s Heroes, Nationwide. <br> •GuideStar Platinum-Rated Nonprofit •Certified-Resource of Wounded Warrior Project & The Green Beret Foundation •Member of The International Society of Stem Cell Research ISSCR & Regenerative Medicine Foundation •Endorsed By The Interventional OrthoBiologic Foundation IOF & The American Academy/Association of Orthopedic Medicine
Quidel Corporation serves to enhance the health and well-being of people around the globe through the development of diagnostic solutions that can lead to improved patient outcomes and provide economic benefits to the healthcare system. As an industry leader in the introduction of rapid tests for a wide range of diseases and medical conditions, Quidel is playing a leading role in the effort to develop rapid, reliable, accessible, and innovative testing for COVID-19, including the first to market FDA EUA approval of the Sofia<sup>®</sup> SARS Antigen FIA rapid test.<br> Quidel products aid in the detection and diagnosis of many other critical diseases and conditions, including influenza, RSV, strep A, ocular surface disease, pregnancy, thyroid conditions, colon cancer, cardiac disease, toxicology and the only rapid diagnostic for Lyme disease. These innovative products are marketed under the Sofia<sup>®</sup>, QuickVue<sup>®</sup>, D3<sup>®</sup> Direct Detection, Thyretain<sup>®</sup>, Triage<sup>®</sup> and InflammaDry<sup>®</sup> brand names, as well as under the Solana<sup>®</sup>, AmpliVue<sup>®</sup> and Lyra<sup>®</sup> molecular diagnostic brands.<br> Quidel’s research and new product development engine is what has historically fueled its growth by developing a continuum of diagnostic tests from advanced immunoassay to molecular diagnostic tests to further improve the quality of healthcare not only in physicians’ offices, hospitals and reference laboratories but in emerging markets such as pharmacies, nursing homes and educational institutions. For more information about Quidel’s comprehensive product portfolio, and to explore exciting employment opportunities, visit quidel.com.
American Headache Society
The mission of the American Headache Society is to improve the care and lives of people living with headache disorders. The American Headache Society (AHS) is a professional society of health care providers dedicated to the study and treatment of headache and face pain. The Society’s objective is to promote the exchange of information and ideas concerning the causes and treatments of headache and related painful disorders. Educating physicians, health professionals, and the public and encouraging scientific research are the primary functions of our Society. AHS activities include an Annual Scientific Meeting, a comprehensive headache symposium, regional symposia for neurologists and family practice physicians, publication of the journal Headache and sponsorship of the American Migraine Foundation.